71 related articles for article (PubMed ID: 30362626)
21. Establishment of a novel ferroptosis-correlative lncRNA signature and validation of ST3GAL4-AS1 for predicting overall survival of hepatocellular carcinoma.
Xuan Z; Liu L; Huang P; Ye Q
Asian J Surg; 2024 May; 47(5):2524-2526. PubMed ID: 38378408
[No Abstract] [Full Text] [Related]
22. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies.
Rashwan HH; Taher AM; Hassan HA; Awaji AA; Kiriacos CJ; Assal RA; Youness RA
Pathol Res Pract; 2024 Apr; 256():155223. PubMed ID: 38452587
[TBL] [Abstract][Full Text] [Related]
23. Claudin-1 as a promoter of EMT in hepatocellular carcinoma.
Stebbing J; Filipović A; Giamas G
Oncogene; 2013 Oct; 32(41):4871-2. PubMed ID: 23318416
[TBL] [Abstract][Full Text] [Related]
24. Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients.
Lim LJ; Ling LH; Neo YP; Chung AYF; Goh BKP; Chow PKH; Chan CY; Cheow PC; Lee SY; Lim TKH; Chong SS; Ooi LLPJ; Lee CG
J Cancer; 2021; 12(11):3098-3113. PubMed ID: 33976720
[TBL] [Abstract][Full Text] [Related]
25. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis.
Wang Z; Luo J; Huang H; Wang L; Lv T; Wang Z; Li C; Wang Y; Liu J; Cheng Q; Zuo X; Hu L; Ye M; Liu H; Song Y
Cell Death Discov; 2024 May; 10(1):240. PubMed ID: 38762546
[TBL] [Abstract][Full Text] [Related]
26. LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway.
Wu W; Zhang Y; Xu C; Yang H; Liu S; Huang G
Mol Cell Biochem; 2024 Apr; 479(4):1011-1022. PubMed ID: 37273040
[TBL] [Abstract][Full Text] [Related]
27. Identification of Robust and Key Differentially Expressed Genes during C2C12 Cell Myogenesis Based on Multiomics Data.
Zhang S; Zhang Y; Chen C; Hu Q; Fu Y; Xu L; Wang C; Liu Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682680
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor c-Myb: novel prognostic factor in osteosarcoma.
Říhová K; Dúcka M; Zambo IS; Vymětalová L; Šrámek M; Trčka F; Verner J; Drápela S; Fedr R; Suchánková T; Pavlatovská B; Ondroušková E; Kubelková I; Zapletalová D; Tuček Š; Múdry P; Krákorová DA; Knopfová L; Šmarda J; Souček K; Borsig L; Beneš P
Clin Exp Metastasis; 2022 Apr; 39(2):375-390. PubMed ID: 34994868
[TBL] [Abstract][Full Text] [Related]
29. Intricate crosstalk between MYB and noncoding RNAs in cancer.
Hu D; Shao W; Liu L; Wang Y; Yuan S; Liu Z; Liu J; Zhang J
Cancer Cell Int; 2021 Dec; 21(1):653. PubMed ID: 34876130
[TBL] [Abstract][Full Text] [Related]
30. Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma.
Liu L; Liu B; Yu J; Zhang D; Shi J; Liang P
Front Mol Biosci; 2021; 8():729789. PubMed ID: 34621787
[No Abstract] [Full Text] [Related]
31. LncRNA LINC00460 takes a stimulating role on hepatocellular carcinoma stemness property.
Chen B; Zhang K; Han Q; Zhong W; Yi J; Zhu H; Xia S
Cell Cycle; 2021 Oct; 20(20):2102-2113. PubMed ID: 34612153
[TBL] [Abstract][Full Text] [Related]
32. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
33. Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Ge X; Yao Y; Li J; Li Z; Han X
Front Oncol; 2021; 11():690800. PubMed ID: 34113574
[TBL] [Abstract][Full Text] [Related]
34. lncRNA LIFR‑AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR‑4698.
Zhao J; Li X; Fu L; Zhang N; Yang J; Cai J
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355363
[TBL] [Abstract][Full Text] [Related]
35. LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
Zhou N; Zhu X; Man L
Cancer Manag Res; 2020; 12():3353-3361. PubMed ID: 32494199
[TBL] [Abstract][Full Text] [Related]
36. Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766.
Shao C; Liu G; Zhang X; Li A; Guo X
Onco Targets Ther; 2020; 13():3013-3024. PubMed ID: 32308432
[TBL] [Abstract][Full Text] [Related]
37. LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression.
Zhou W; Huang K; Zhang Q; Ye S; Zhong Z; Zeng C; Peng G; Li L; Ye Q
PeerJ; 2020; 8():e8394. PubMed ID: 32025371
[TBL] [Abstract][Full Text] [Related]
38. miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.
Gao Y; Zhang W; Liu C; Li G
Sci Rep; 2019 Dec; 9(1):18844. PubMed ID: 31827114
[TBL] [Abstract][Full Text] [Related]
39. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
Nai Y; Pan C; Hu X; Ma Y
Cancer Med; 2020 Jan; 9(2):757-767. PubMed ID: 31789465
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA DRHC inhibits the proliferation of cancer cells in triple negative breast cancer by downregulating long non-coding RNA HOTAIR.
Yu F; Wang L; Zhang B
Oncol Lett; 2019 Oct; 18(4):3817-3822. PubMed ID: 31516593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
